Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiosurgery | 8 | 2024 | 1331 | 2.730 |
Why?
|
| Glomus Jugulare Tumor | 2 | 2020 | 37 | 1.480 |
Why?
|
| Brain Neoplasms | 14 | 2024 | 8856 | 1.190 |
Why?
|
| Oligodendroglioma | 1 | 2022 | 279 | 0.770 |
Why?
|
| Photons | 3 | 2023 | 588 | 0.750 |
Why?
|
| Protons | 3 | 2023 | 1129 | 0.680 |
Why?
|
| Neuroma, Acoustic | 1 | 2022 | 451 | 0.630 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2022 | 740 | 0.560 |
Why?
|
| Glioblastoma | 4 | 2024 | 3480 | 0.480 |
Why?
|
| Glioma | 3 | 2023 | 3401 | 0.470 |
Why?
|
| Prostatic Neoplasms | 4 | 2024 | 11059 | 0.420 |
Why?
|
| Sarcoma | 4 | 2023 | 1898 | 0.390 |
Why?
|
| Soft Tissue Neoplasms | 3 | 2023 | 1363 | 0.330 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 2210 | 0.320 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2024 | 5230 | 0.290 |
Why?
|
| Astrocytoma | 2 | 2021 | 790 | 0.270 |
Why?
|
| Multicenter Studies as Topic | 2 | 2022 | 1676 | 0.270 |
Why?
|
| Lateral Ventricles | 2 | 2024 | 146 | 0.260 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 4260 | 0.260 |
Why?
|
| Tumor Burden | 2 | 2020 | 1917 | 0.240 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2023 | 895 | 0.230 |
Why?
|
| Neurofibrosarcoma | 1 | 2023 | 24 | 0.230 |
Why?
|
| Prostate-Specific Antigen | 2 | 2023 | 2471 | 0.220 |
Why?
|
| Lung Neoplasms | 3 | 2024 | 13112 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2022 | 367 | 0.200 |
Why?
|
| Methylation | 1 | 2024 | 1104 | 0.190 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2023 | 871 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2022 | 657 | 0.180 |
Why?
|
| Eye Proteins | 1 | 2024 | 645 | 0.180 |
Why?
|
| Ependymoma | 1 | 2023 | 334 | 0.180 |
Why?
|
| Adrenal Glands | 1 | 2022 | 547 | 0.170 |
Why?
|
| Radiotherapy Dosage | 2 | 2023 | 2879 | 0.170 |
Why?
|
| Retrospective Studies | 14 | 2024 | 77410 | 0.160 |
Why?
|
| Radiometry | 1 | 2022 | 800 | 0.140 |
Why?
|
| Humans | 29 | 2024 | 743811 | 0.140 |
Why?
|
| Prostate | 1 | 2022 | 1763 | 0.120 |
Why?
|
| Androgen Antagonists | 1 | 2022 | 1376 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 2914 | 0.110 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2022 | 1624 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 2916 | 0.110 |
Why?
|
| DNA Methylation | 2 | 2023 | 4286 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2023 | 3758 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 39001 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2023 | 9239 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 35409 | 0.080 |
Why?
|
| Nerve Net | 1 | 2019 | 2173 | 0.080 |
Why?
|
| Treatment Outcome | 4 | 2023 | 63042 | 0.070 |
Why?
|
| Brain | 4 | 2023 | 26345 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2020 | 3320 | 0.070 |
Why?
|
| Positron-Emission Tomography | 1 | 2022 | 6237 | 0.070 |
Why?
|
| Melanoma | 1 | 2023 | 5508 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2024 | 53250 | 0.050 |
Why?
|
| Metabolomics | 2 | 2023 | 1487 | 0.050 |
Why?
|
| Ciliary Body | 1 | 2023 | 173 | 0.050 |
Why?
|
| Mutation | 2 | 2023 | 29777 | 0.050 |
Why?
|
| Karnofsky Performance Status | 1 | 2020 | 173 | 0.050 |
Why?
|
| Male | 6 | 2024 | 349776 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2023 | 10251 | 0.040 |
Why?
|
| Quality of Life | 1 | 2020 | 12788 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 8035 | 0.040 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2021 | 627 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2022 | 1770 | 0.040 |
Why?
|
| Extremities | 1 | 2022 | 867 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2021 | 1154 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2022 | 12954 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2023 | 1358 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2021 | 1205 | 0.030 |
Why?
|
| Neurilemmoma | 1 | 2020 | 547 | 0.030 |
Why?
|
| Cartilage | 1 | 2017 | 818 | 0.030 |
Why?
|
| Reference Values | 1 | 2019 | 4974 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2020 | 2307 | 0.030 |
Why?
|
| Genital Neoplasms, Female | 1 | 2017 | 523 | 0.030 |
Why?
|
| Biopsy | 1 | 2023 | 6750 | 0.030 |
Why?
|
| Adult | 5 | 2023 | 213889 | 0.030 |
Why?
|
| Prognosis | 2 | 2023 | 29052 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2023 | 8637 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 2727 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 3591 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8316 | 0.020 |
Why?
|
| tau Proteins | 1 | 2019 | 1869 | 0.020 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2017 | 991 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2019 | 5096 | 0.020 |
Why?
|
| Contrast Media | 1 | 2020 | 5301 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 3587 | 0.020 |
Why?
|
| Young Adult | 2 | 2023 | 56392 | 0.020 |
Why?
|
| Child | 2 | 2023 | 77637 | 0.020 |
Why?
|
| Aged | 3 | 2023 | 163178 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 15067 | 0.010 |
Why?
|
| Middle Aged | 3 | 2023 | 213241 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13273 | 0.010 |
Why?
|
| Female | 3 | 2020 | 380020 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 57744 | 0.010 |
Why?
|
| Adolescent | 1 | 2023 | 85729 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 72252 | 0.010 |
Why?
|
Concepts
(94)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_